Plunkett Research Online: Vertex Pharmaceuticals Incorporated

VERTEX PHARMACEUTICALS INCORPORATED (VRTX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vertex Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs for the treatment of serious diseases. Vertex’s business focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF), as well as advancing its research & development programs i.....



Vertex Pharmaceuticals Incorporated
Ticker: VRTX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 444-6100
Fax:
Address: 50 Northern Avenue
Boston, MA 02210 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Small Molecule Drugs
ContactsDescription
Jeffrey LeidenCEO/Chairman of the Board/Director/President
Thomas GraneyCFO/Senior VP
See More

Auditor: Ernst & Young LLP
Legal Advisor: Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ORKAMBI
KALYDECO
SYMDEKO
VX-659
VX-445
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

Employee benefits include four weeks of vacation from the first day of employment; an employee stock purchase plan; life, disability, AD&D, medical, dental, prescription and vision insurance; and financial and wellness programs.